Looker Benjamin
SEC insider (Form 3/4/5 filer). CIK 0001859509. Chief Legal Officer at Esperion Therapeutics, Inc. (ESPR). 11 reported Form 4/5 transactions since Sep 2024; latest on Jul 13, 2026. Located in ANN ARBOR, MI.
Companies Looker Benjamin has filed insider reports for
- Esperion Therapeutics, Inc. (ESPR): Officer, Chief Legal Officer
Looker Benjamin
CIK: 0001859509
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Esperion Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Jul 13, 2026ESPR
Esperion Therapeutics, Inc.
DispositionDirect667.5K shares- - Jun 17, 2026ESPR
Esperion Therapeutics, Inc.
SaleDirect11.8K shares at avg. $3.15$37K - Mar 17, 2026ESPR
Esperion Therapeutics, Inc.
SaleDirect5.7K shares at avg. $2.70$15K - Mar 13, 2026ESPR
Esperion Therapeutics, Inc.
AwardDirect300.8K shares- - Jan 20, 2026ESPR
Esperion Therapeutics, Inc.
SaleDirect1.7K shares at avg. $2.88$5K - Dec 17, 2025ESPR
Esperion Therapeutics, Inc.
SaleDirect6.5K shares at avg. $3.67$24K - Oct 17, 2025ESPR
Esperion Therapeutics, Inc.
SaleDirect1.2K shares at avg. $2.62$3K - Sep 17, 2025ESPR
Esperion Therapeutics, Inc.
SaleDirect6.3K shares at avg. $2.80$18K - Jul 17, 2025ESPR
Esperion Therapeutics, Inc.
SaleDirect1.3K shares at avg. $1.13$1K - Jun 17, 2025ESPR
Esperion Therapeutics, Inc.
SaleDirect6.4K shares at avg. $1.15$7K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 13, 2026 | ESPR Esperion Therapeutics, Inc. | Disposition | 667,524 | - | $0 | Direct |
| Jun 17, 2026 | ESPR Esperion Therapeutics, Inc. | Sale | 11,824 | $3.15 | $37,305 | Direct |
| Mar 17, 2026 | ESPR Esperion Therapeutics, Inc. | Sale | 5,708 | $2.70 | $15,429 | Direct |
| Mar 13, 2026 | ESPR Esperion Therapeutics, Inc. | Award | 300,840 | - | $0 | Direct |
| Jan 20, 2026 | ESPR Esperion Therapeutics, Inc. | Sale | 1,689 | $2.88 | $4,868 | Direct |
| Dec 17, 2025 | ESPR Esperion Therapeutics, Inc. | Sale | 6,517 | $3.67 | $23,898 | Direct |
| Oct 17, 2025 | ESPR Esperion Therapeutics, Inc. | Sale | 1,248 | $2.62 | $3,275 | Direct |
| Sep 17, 2025 | ESPR Esperion Therapeutics, Inc. | Sale | 6,267 | $2.80 | $17,573 | Direct |
| Jul 17, 2025 | ESPR Esperion Therapeutics, Inc. | Sale | 1,304 | $1.13 | $1,470 | Direct |
| Jun 17, 2025 | ESPR Esperion Therapeutics, Inc. | Sale | 6,422 | $1.15 | $7,398 | Direct |
1-10 of 11 transactions